All News about Sesen Bio Inc
Via Benzinga
Sesen Bio Announces Anticipated Regulatory Path Forward for Vicineum™
December 09, 2021
From Sesen Bio, Inc.
Via Business Wire
From Sesen Bio
Via Business Wire
Sesen Bio, Inc. (NASDAQ:SESN) Long Term Investor Alert: Investigation of Potential Wrongdoing
November 18, 2021
Via SBWire
Topics
Lawsuit
From Sesen Bio
Via Business Wire
Sesen Bio Announces Productive CMC Type A Meeting with the FDA
November 01, 2021
From Sesen Bio
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.